REPOZYTORIUM UNIWERSYTETU
W BIAŁYMSTOKU
UwB

Proszę używać tego identyfikatora do cytowań lub wstaw link do tej pozycji: http://hdl.handle.net/11320/16602
Tytuł: Doxorubicin-loaded polymeric nanoparticles containing ketoester-based block and cholesterol moiety as specific vehicles to fight estrogen-dependent breast cancer
Autorzy: Misiak, Paweł
Niemirowicz - Laskowska, Katarzyna
Markiewicz, Karolina H.
Wielgat, Przemysław
Kurowska, Izabela
Czarnomysy, Robert
Misztalewska - Turkowicz, Iwona
Car, Halina
Bielawski, Krzysztof
Wilczewska, Agnieszka Z.
Słowa kluczowe: Polymeric nanoparticles
Cholesterol-end capped poly (Nisopropylacrylamide)
Cell-penetrating molecules
Breast cancer
Doxorubicin
Smart drug delivery systems
Data wydania: 2023
Data dodania: 4-cze-2024
Wydawca: BMC
Źródło: Cancer Nanotechnology, Volume 14 (2023), p. 1-25
Abstrakt: The presented research concerns the preparation of polymer nanoparticles (PNPs) for the delivery of doxorubicin. Several block and statistical copolymers, composed of ketoester derivative, N-isopropylacrylamide, and cholesterol, were synthesized. In the nanoprecipitation process, doxorubicin (DOX) molecules were kept in spatial polymeric systems. DOX-loaded PNPs show high efcacy against estrogen-dependent MCF-7 breast cancer cell lines despite low doses of DOX applied and good compatibility with normal cells. Research confrms the efect of PNPs on the degradation of the biological membrane, and the accumulation of reactive oxygen species (ROS), and the ability to cell cycle arrest are strictly linked to cell death.
Afiliacja: Paweł Misiak - Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15‑245 Białystok, Poland
Katarzyna Niemirowicz‑Laskowska - Department of Experimental Pharmacology, Medical University of Bialystok, Mickiewicza 2A, 15‑089 Białystok, Poland
Karolina H. Markiewicz - Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15‑245 Białystok, Poland
Przemysław Wielgat - Department of Clinical Pharmacology, Medical University of Bialystok, Białystok, Poland
Izabela Kurowska - Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15‑245 Białystok, Poland
Robert Czarnomysy - Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15‑089 Białystok, Poland
Iwona Misztalewska‑Turkowicz - Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15‑245 Białystok, Poland
Halina Car - Department of Experimental Pharmacology, Medical University of Bialystok, Mickiewicza 2A, 15‑089 Białystok, Poland
Krzysztof Bielawski - Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15‑089 Białystok, Poland
Agnieszka Z. Wilczewska - Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15‑245 Białystok, Poland
E-mail: Katarzyna Niemirowicz‑Laskowska: katarzyna.niemirowicz@umb.edu.pl
Agnieszka Z. Wilczewska: agawilcz@uwb.edu.pl
Sponsorzy: This work was fnancially supported by the National Science Centre, Poland, grant no. NCN/2016/21/B/ST5/01365.
URI: http://hdl.handle.net/11320/16602
DOI: 10.1186/s12645-023-00176-9
ISSN: 1868-6966
Typ Dokumentu: Article
metadata.dc.rights.uri: http://creativecommons.org/licenses/by/4.0/
Właściciel praw: © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
Występuje w kolekcji(ach):Artykuły naukowe (WChem)

Pokaż pełny widok rekordu Zobacz statystyki


Pozycja ta dostępna jest na podstawie licencji Licencja Creative Commons CCL Creative Commons